Cargando…

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?

Detalles Bibliográficos
Autor principal:	Gurjar, Mohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071676/ https://www.ncbi.nlm.nih.gov/pubmed/24987231 http://dx.doi.org/10.4103/0972-5229.133867

Ejemplares similares

Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis
por: Li, Guowei, et al.
Publicado: (2016)

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Renal function and thromboprophylaxis in critically ill patients
por: Scholey, Gareth M, et al.
Publicado: (2010)

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
por: Ferrandis, R., et al.
Publicado: (2023)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
por: Piagnerelli, Michaël, et al.
Publicado: (2020)

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial
por: Pai, Menaka, et al.
Publicado: (2018)

Towards Achieving Nutrition Goal in Critically Ill Patients: Need a Simple Yet Effective Bedside Tool
por: Wali, Sachin, et al.
Publicado: (2023)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)

Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
por: Jonmarker, Sandra, et al.
Publicado: (2020)

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection
por: Kummer, R.L., et al.
Publicado: (2021)

Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
por: de Montmollin, Etienne, et al.
Publicado: (2021)

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Is this patient really “(un)stable”? How to describe cardiovascular dynamics in critically ill patients
por: Vincent, Jean-Louis, et al.
Publicado: (2019)

Extended thromboprophylaxis with betrixaban: a new standard for acute medically ill patients
por: Cohen, Alexander T
Publicado: (2018)

Postpartum Heparin Thromboprophylaxis: More Harm Than Good
por: Kotaska, Andrew
Publicado: (2021)

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit
por: Lauzier, François, et al.
Publicado: (2014)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Thromboprophylaxis in Patients With Cancer and COVID-19
por: Lecumberri, Ramón, et al.
Publicado: (2022)

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study
por: Eman, Ali, et al.
Publicado: (2022)

Cardiac manifestations in critically ill patients with COVID-19: do we really know what hit us?
por: Hjortrup, Peter Buhl, et al.
Publicado: (2022)

An unusual case of bilateral pulmonary embolism in a patient on dual venous thromboprophylaxis, secondary to heparin induced thrombocytopenia
por: Lixon, Antony, et al.
Publicado: (2018)

Pharmacological thromboprophylaxis and epidural anaesthesia
por: Harsoor, SS, et al.
Publicado: (2012)

The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
por: Wei, Matthew Y., et al.
Publicado: (2015)

Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis
por: Matsumoto, Mio, et al.
Publicado: (2015)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
por: Cauchie, Philippe, et al.
Publicado: (2021)

Integral assays of hemostasis in hospitalized patients with COVID-19 on admission and during heparin thromboprophylaxis
por: Bulanov, Andrey Y., et al.
Publicado: (2023)

Current concepts in combination antibiotic therapy for critically ill patients
por: Ahmed, Armin, et al.
Publicado: (2014)

Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials
por: Park, Jonghanne, et al.
Publicado: (2016)

Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection
por: Fattorutto, Maurizio, et al.
Publicado: (2021)

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
por: MacDougall, Kira, et al.
Publicado: (2020)

Blood Glucose Variability and Outcomes in Critically Ill Children
por: Naranje, Kirti Mahadeorao, et al.
Publicado: (2017)

Facial nerve involvement in critical illness polyneuropathy
por: Gurjar, Mohan, et al.
Publicado: (2010)

Critically Ill Obstetric Patients and Fetomaternal Outcome
por: Bande, Balasaheb D
Publicado: (2020)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
por: Huang, Jia-Jia, et al.
Publicado: (2023)

Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis
por: Coleman, Craig I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_feo8ovngh0bu2indatmqbknlfu